Open an account

Viemed Healthcare

VMD · NASDAQ

$9.80+$0.21 (+2.19%)TodayMarket closed ·
Prev close $9.59

About VMD

Viemed Healthcare, Inc. engages in the provision of home healthcare solutions. The company is headquartered in Lafayette, Louisiana and currently employs 1,382 full-time employees. The company went IPO on 2017-12-22. The firm focuses on in-home treatment with clinical practitioners providing therapy, education and counseling to patients in their homes using high-touch and high-tech services. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment solutions, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, oxygen concentrators, breast pumps for women, respiratory devices and other medical equipment. The company offers in-home sleep apnea testing services. The firm also provides healthcare staffing and recruitment services.

Employees
1,387
Headquarters
Lafayette, Louisiana
Listed
Dec 22, 2017
Sector
Health Care
Industry
Health Care Providers & Services
Website
viemed.com

VMD key statistics

Market cap
361.08M
Price-earnings ratio
26.64
Dividend yield
—
Average volume
241.83K
Volume
179.94K
Open price
$9.68
High today
$9.83
Low today
$9.59
52 Week high
$12.61
52 Week low
$6.05

Viemed Healthcare (VMD) at a glance

Viemed Healthcare (VMD) last traded at $9.80, with a market cap of 361.08M and a price-to-earnings ratio of 26.64.

Today the stock has traded between $9.59 and $9.83. The current price is 2.2% above the day's low and 0.3% below its high.

Volume so far is 179.94K shares, below the average of 241.83K shares a day.

Over the past year Viemed Healthcare has ranged from $6.05 to $12.61, and now sits 57% of the way up that range.

Viemed Healthcare met or beat analyst EPS estimates in 2 of the last 8 quarters. In Q2 FY26 it reported $0.07 per share against an estimate of $0.1212.

The average analyst price target is $12.75, 30.1% above the current price, from 2 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

50%of 2 analyst ratings say Buy
  • Buy50.0%
  • Hold50.0%
  • Sell0.0%
Price target · 3 analystsAvg $12.75
Low
$11.11
Now
$9.80
High
$14.70

VMD earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 2 of the last 8 quarters, by 21.4% on average.

  1. Q3 FY24: reported $0.10 per share against an estimate of $0.0758
  2. Q4 FY24: reported $0.10 per share against an estimate of $0.1061
  3. Q1 FY25: reported $0.06 per share against an estimate of $0.0606
  4. Q2 FY25: reported $0.08 per share against an estimate of $0.0808
  5. Q3 FY25: reported $0.09 per share against an estimate of $0.0909
  6. Q4 FY25: reported $0.14 per share against an estimate of $0.1263
  7. Q1 FY26: reported $0.06 per share against an estimate of $0.0909
  8. Q2 FY26: reported $0.07 per share against an estimate of $0.1212

VMD news

  • 12 Health Care Stocks Moving In Tuesday's Intraday Session

  • Viemed Healthcare Q1 2026 Earnings Call: Complete Transcript

  • A Peek at Viemed Healthcare's Future Earnings

  • Viemed Healthcare's Earnings: A Preview

  • Avi Kapoor

    Super Micro Computer And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Similar companies

Companies in the same industry as Viemed Healthcare

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.